The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vaginal Anti Infectives Market Research Report 2025
Synopsis
Vaginal anti-infectives are the type of agents that are used for the killing or supressing the infection of vagina caused by numerous bacteria, virus, fungi or micro-organism. These bacteria and others invade the host by means of its replication or releasing several toxins into the host. "Yeast" infections, tyrichomoniasis vaginitis, bacterial vaginosis, chlamydia vaginitis, and viral vaginitis are the major forms of vaginitis. About one third women all over the world experience indications of vaginitis at some point in their lifetime. Women are highly prone to vaginitis during the reproductive age; a change in the balance of bacteria and yeast present in vagina can lead to vaginitis.
Highlights
The global Vaginal Anti Infectives market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Vaginal Anti Infectives is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Vaginal Anti Infectives is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Vaginal Anti Infectives include Pfizer Inc, Mylan N.V, Novartis AG, Hikma Pharmaceuticals plc, Aurobindo Pharma, AbbVie Inc, Melinta Therapeutics, Inc, Bristol-Myers Squibb Company and GSK plc, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Vaginal Anti Infectives in Bacterial Vaginitis is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Oral, which accounted for % of the global market of Vaginal Anti Infectives in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaginal Anti Infectives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaginal Anti Infectives.
The Vaginal Anti Infectives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Vaginal Anti Infectives market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaginal Anti Infectives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Pfizer Inc
Mylan N.V
Novartis AG
Hikma Pharmaceuticals plc
Aurobindo Pharma
AbbVie Inc
Melinta Therapeutics, Inc
Bristol-Myers Squibb Company
GSK plc
Bayer AG
Lupin
Perrigo Company plc
Product Type Insights
Global markets are presented by Vaginal Anti Infectives type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Vaginal Anti Infectives are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Vaginal Anti Infectives segment by Type
Oral
Ointment
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Vaginal Anti Infectives market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Vaginal Anti Infectives market.
Vaginal Anti Infectives segment by Application
Bacterial Vaginitis
Trichomonal Vaginitis
Candida Vaginitis
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Vaginal Anti Infectives market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaginal Anti Infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Vaginal Anti Infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Vaginal Anti Infectives industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaginal Anti Infectives.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaginal Anti Infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaginal Anti Infectives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Vaginal anti-infectives are the type of agents that are used for the killing or supressing the infection of vagina caused by numerous bacteria, virus, fungi or micro-organism. These bacteria and others invade the host by means of its replication or releasing several toxins into the host. "Yeast" infections, tyrichomoniasis vaginitis, bacterial vaginosis, chlamydia vaginitis, and viral vaginitis are the major forms of vaginitis. About one third women all over the world experience indications of vaginitis at some point in their lifetime. Women are highly prone to vaginitis during the reproductive age; a change in the balance of bacteria and yeast present in vagina can lead to vaginitis.
Highlights
The global Vaginal Anti Infectives market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Vaginal Anti Infectives is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Vaginal Anti Infectives is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Vaginal Anti Infectives include Pfizer Inc, Mylan N.V, Novartis AG, Hikma Pharmaceuticals plc, Aurobindo Pharma, AbbVie Inc, Melinta Therapeutics, Inc, Bristol-Myers Squibb Company and GSK plc, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Vaginal Anti Infectives in Bacterial Vaginitis is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Oral, which accounted for % of the global market of Vaginal Anti Infectives in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaginal Anti Infectives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaginal Anti Infectives.
The Vaginal Anti Infectives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Vaginal Anti Infectives market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaginal Anti Infectives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Pfizer Inc
Mylan N.V
Novartis AG
Hikma Pharmaceuticals plc
Aurobindo Pharma
AbbVie Inc
Melinta Therapeutics, Inc
Bristol-Myers Squibb Company
GSK plc
Bayer AG
Lupin
Perrigo Company plc
Product Type Insights
Global markets are presented by Vaginal Anti Infectives type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Vaginal Anti Infectives are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Vaginal Anti Infectives segment by Type
Oral
Ointment
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Vaginal Anti Infectives market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Vaginal Anti Infectives market.
Vaginal Anti Infectives segment by Application
Bacterial Vaginitis
Trichomonal Vaginitis
Candida Vaginitis
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Vaginal Anti Infectives market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaginal Anti Infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Vaginal Anti Infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Vaginal Anti Infectives industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaginal Anti Infectives.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaginal Anti Infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaginal Anti Infectives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Index1 Vaginal Anti Infectives Market Overview
1.1 Product Overview and Scope of Vaginal Anti Infectives
1.2 Vaginal Anti Infectives Segment by Type
1.2.1 Global Vaginal Anti Infectives Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Oral
1.2.3 Ointment
1.3 Vaginal Anti Infectives Segment by Application
1.3.1 Global Vaginal Anti Infectives Sales Comparison by Application: (2022-2028)
1.3.2 Bacterial Vaginitis
1.3.3 Trichomonal Vaginitis
1.3.4 Candida Vaginitis
1.4 Global Vaginal Anti Infectives Market Size Estimates and Forecasts
1.4.1 Global Vaginal Anti Infectives Revenue 2017-2028
1.4.2 Global Vaginal Anti Infectives Sales 2017-2028
1.4.3 Vaginal Anti Infectives Market Size by Region: 2017 Versus 2021 Versus 2028
2 Vaginal Anti Infectives Market Competition by Manufacturers
2.1 Global Vaginal Anti Infectives Sales Market Share by Manufacturers (2017-2022)
2.2 Global Vaginal Anti Infectives Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Vaginal Anti Infectives Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Vaginal Anti Infectives Manufacturing Sites, Area Served, Product Type
2.5 Vaginal Anti Infectives Market Competitive Situation and Trends
2.5.1 Vaginal Anti Infectives Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Vaginal Anti Infectives Players Market Share by Revenue
2.5.3 Global Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaginal Anti Infectives Retrospective Market Scenario by Region
3.1 Global Vaginal Anti Infectives Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Vaginal Anti Infectives Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Vaginal Anti Infectives Market Facts & Figures by Country
3.3.1 North America Vaginal Anti Infectives Sales by Country
3.3.2 North America Vaginal Anti Infectives Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Vaginal Anti Infectives Market Facts & Figures by Country
3.4.1 Europe Vaginal Anti Infectives Sales by Country
3.4.2 Europe Vaginal Anti Infectives Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vaginal Anti Infectives Market Facts & Figures by Region
3.5.1 Asia Pacific Vaginal Anti Infectives Sales by Region
3.5.2 Asia Pacific Vaginal Anti Infectives Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Vaginal Anti Infectives Market Facts & Figures by Country
3.6.1 Latin America Vaginal Anti Infectives Sales by Country
3.6.2 Latin America Vaginal Anti Infectives Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Vaginal Anti Infectives Market Facts & Figures by Country
3.7.1 Middle East and Africa Vaginal Anti Infectives Sales by Country
3.7.2 Middle East and Africa Vaginal Anti Infectives Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Vaginal Anti Infectives Historic Market Analysis by Type
4.1 Global Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
4.2 Global Vaginal Anti Infectives Revenue Market Share by Type (2017-2022)
4.3 Global Vaginal Anti Infectives Price by Type (2017-2022)
5 Global Vaginal Anti Infectives Historic Market Analysis by Application
5.1 Global Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
5.2 Global Vaginal Anti Infectives Revenue Market Share by Application (2017-2022)
5.3 Global Vaginal Anti Infectives Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer Inc
6.1.1 Pfizer Inc Corporation Information
6.1.2 Pfizer Inc Description and Business Overview
6.1.3 Pfizer Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Inc Vaginal Anti Infectives Product Portfolio
6.1.5 Pfizer Inc Recent Developments/Updates
6.2 Mylan N.V
6.2.1 Mylan N.V Corporation Information
6.2.2 Mylan N.V Description and Business Overview
6.2.3 Mylan N.V Vaginal Anti Infectives Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Mylan N.V Vaginal Anti Infectives Product Portfolio
6.2.5 Mylan N.V Recent Developments/Updates
6.3 Novartis AG
6.3.1 Novartis AG Corporation Information
6.3.2 Novartis AG Description and Business Overview
6.3.3 Novartis AG Vaginal Anti Infectives Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Novartis AG Vaginal Anti Infectives Product Portfolio
6.3.5 Novartis AG Recent Developments/Updates
6.4 Hikma Pharmaceuticals plc
6.4.1 Hikma Pharmaceuticals plc Corporation Information
6.4.2 Hikma Pharmaceuticals plc Description and Business Overview
6.4.3 Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Portfolio
6.4.5 Hikma Pharmaceuticals plc Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Vaginal Anti Infectives Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Aurobindo Pharma Vaginal Anti Infectives Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 AbbVie Inc
6.6.1 AbbVie Inc Corporation Information
6.6.2 AbbVie Inc Description and Business Overview
6.6.3 AbbVie Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2017-2022)
6.6.4 AbbVie Inc Vaginal Anti Infectives Product Portfolio
6.6.5 AbbVie Inc Recent Developments/Updates
6.7 Melinta Therapeutics, Inc
6.6.1 Melinta Therapeutics, Inc Corporation Information
6.6.2 Melinta Therapeutics, Inc Description and Business Overview
6.6.3 Melinta Therapeutics, Inc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Portfolio
6.7.5 Melinta Therapeutics, Inc Recent Developments/Updates
6.8 Bristol-Myers Squibb Company
6.8.1 Bristol-Myers Squibb Company Corporation Information
6.8.2 Bristol-Myers Squibb Company Description and Business Overview
6.8.3 Bristol-Myers Squibb Company Vaginal Anti Infectives Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Portfolio
6.8.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.9 GSK plc
6.9.1 GSK plc Corporation Information
6.9.2 GSK plc Description and Business Overview
6.9.3 GSK plc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2017-2022)
6.9.4 GSK plc Vaginal Anti Infectives Product Portfolio
6.9.5 GSK plc Recent Developments/Updates
6.10 Bayer AG
6.10.1 Bayer AG Corporation Information
6.10.2 Bayer AG Description and Business Overview
6.10.3 Bayer AG Vaginal Anti Infectives Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Bayer AG Vaginal Anti Infectives Product Portfolio
6.10.5 Bayer AG Recent Developments/Updates
6.11 Lupin
6.11.1 Lupin Corporation Information
6.11.2 Lupin Vaginal Anti Infectives Description and Business Overview
6.11.3 Lupin Vaginal Anti Infectives Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Lupin Vaginal Anti Infectives Product Portfolio
6.11.5 Lupin Recent Developments/Updates
6.12 Perrigo Company plc
6.12.1 Perrigo Company plc Corporation Information
6.12.2 Perrigo Company plc Vaginal Anti Infectives Description and Business Overview
6.12.3 Perrigo Company plc Vaginal Anti Infectives Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Perrigo Company plc Vaginal Anti Infectives Product Portfolio
6.12.5 Perrigo Company plc Recent Developments/Updates
7 Vaginal Anti Infectives Manufacturing Cost Analysis
7.1 Vaginal Anti Infectives Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vaginal Anti Infectives
7.4 Vaginal Anti Infectives Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Vaginal Anti Infectives Distributors List
8.3 Vaginal Anti Infectives Customers
9 Vaginal Anti Infectives Market Dynamics
9.1 Vaginal Anti Infectives Industry Trends
9.2 Vaginal Anti Infectives Market Drivers
9.3 Vaginal Anti Infectives Market Challenges
9.4 Vaginal Anti Infectives Market Restraints
10 Global Market Forecast
10.1 Vaginal Anti Infectives Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vaginal Anti Infectives by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Vaginal Anti Infectives by Type (2023-2028)
10.2 Vaginal Anti Infectives Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vaginal Anti Infectives by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Vaginal Anti Infectives by Application (2023-2028)
10.3 Vaginal Anti Infectives Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vaginal Anti Infectives by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Vaginal Anti Infectives by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Vaginal Anti Infectives Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Vaginal Anti Infectives Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Vaginal Anti Infectives Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Vaginal Anti Infectives Market Competitive Situation by Manufacturers in 2021
Table 5. Global Vaginal Anti Infectives Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Vaginal Anti Infectives Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Vaginal Anti Infectives Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Vaginal Anti Infectives Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Vaginal Anti Infectives Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Vaginal Anti Infectives Manufacturing Sites and Area Served
Table 11. Manufacturers Vaginal Anti Infectives Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Vaginal Anti Infectives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaginal Anti Infectives as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Vaginal Anti Infectives Sales by Region (2017-2022) & (K Units)
Table 16. Global Vaginal Anti Infectives Sales Market Share by Region (2017-2022)
Table 17. Global Vaginal Anti Infectives Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Vaginal Anti Infectives Revenue Market Share by Region (2017-2022)
Table 19. North America Vaginal Anti Infectives Sales by Country (2017-2022) & (K Units)
Table 20. North America Vaginal Anti Infectives Sales Market Share by Country (2017-2022)
Table 21. North America Vaginal Anti Infectives Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Vaginal Anti Infectives Revenue Market Share by Country (2017-2022)
Table 23. Europe Vaginal Anti Infectives Sales by Country (2017-2022) & (K Units)
Table 24. Europe Vaginal Anti Infectives Sales Market Share by Country (2017-2022)
Table 25. Europe Vaginal Anti Infectives Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Vaginal Anti Infectives Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Vaginal Anti Infectives Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Vaginal Anti Infectives Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Vaginal Anti Infectives Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Vaginal Anti Infectives Revenue Market Share by Region (2017-2022)
Table 31. Latin America Vaginal Anti Infectives Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Vaginal Anti Infectives Sales Market Share by Country (2017-2022)
Table 33. Latin America Vaginal Anti Infectives Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Vaginal Anti Infectives Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Vaginal Anti Infectives Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Vaginal Anti Infectives Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Vaginal Anti Infectives Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Vaginal Anti Infectives Revenue Market Share by Country (2017-2022)
Table 39. Global Vaginal Anti Infectives Sales by Type (2017-2022) & (K Units)
Table 40. Global Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
Table 41. Global Vaginal Anti Infectives Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Vaginal Anti Infectives Revenue Share by Type (2017-2022)
Table 43. Global Vaginal Anti Infectives Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Vaginal Anti Infectives Sales (K Units) by Application (2017-2022)
Table 45. Global Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
Table 46. Global Vaginal Anti Infectives Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Vaginal Anti Infectives Revenue Share by Application (2017-2022)
Table 48. Global Vaginal Anti Infectives Price by Application (2017-2022) & (US$/Unit)
Table 49. Pfizer Inc Corporation Information
Table 50. Pfizer Inc Description and Business Overview
Table 51. Pfizer Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Pfizer Inc Vaginal Anti Infectives Product
Table 53. Pfizer Inc Recent Developments/Updates
Table 54. Mylan N.V Corporation Information
Table 55. Mylan N.V Description and Business Overview
Table 56. Mylan N.V Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Mylan N.V Vaginal Anti Infectives Product
Table 58. Mylan N.V Recent Developments/Updates
Table 59. Novartis AG Corporation Information
Table 60. Novartis AG Description and Business Overview
Table 61. Novartis AG Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Novartis AG Vaginal Anti Infectives Product
Table 63. Novartis AG Recent Developments/Updates
Table 64. Hikma Pharmaceuticals plc Corporation Information
Table 65. Hikma Pharmaceuticals plc Description and Business Overview
Table 66. Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Hikma Pharmaceuticals plc Vaginal Anti Infectives Product
Table 68. Hikma Pharmaceuticals plc Recent Developments/Updates
Table 69. Aurobindo Pharma Corporation Information
Table 70. Aurobindo Pharma Description and Business Overview
Table 71. Aurobindo Pharma Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Aurobindo Pharma Vaginal Anti Infectives Product
Table 73. Aurobindo Pharma Recent Developments/Updates
Table 74. AbbVie Inc Corporation Information
Table 75. AbbVie Inc Description and Business Overview
Table 76. AbbVie Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. AbbVie Inc Vaginal Anti Infectives Product
Table 78. AbbVie Inc Recent Developments/Updates
Table 79. Melinta Therapeutics, Inc Corporation Information
Table 80. Melinta Therapeutics, Inc Description and Business Overview
Table 81. Melinta Therapeutics, Inc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Melinta Therapeutics, Inc Vaginal Anti Infectives Product
Table 83. Melinta Therapeutics, Inc Recent Developments/Updates
Table 84. Bristol-Myers Squibb Company Corporation Information
Table 85. Bristol-Myers Squibb Company Description and Business Overview
Table 86. Bristol-Myers Squibb Company Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Bristol-Myers Squibb Company Vaginal Anti Infectives Product
Table 88. Bristol-Myers Squibb Company Recent Developments/Updates
Table 89. GSK plc Corporation Information
Table 90. GSK plc Description and Business Overview
Table 91. GSK plc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. GSK plc Vaginal Anti Infectives Product
Table 93. GSK plc Recent Developments/Updates
Table 94. Bayer AG Corporation Information
Table 95. Bayer AG Description and Business Overview
Table 96. Bayer AG Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Bayer AG Vaginal Anti Infectives Product
Table 98. Bayer AG Recent Developments/Updates
Table 99. Lupin Corporation Information
Table 100. Lupin Description and Business Overview
Table 101. Lupin Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Lupin Vaginal Anti Infectives Product
Table 103. Lupin Recent Developments/Updates
Table 104. Perrigo Company plc Corporation Information
Table 105. Perrigo Company plc Description and Business Overview
Table 106. Perrigo Company plc Vaginal Anti Infectives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Perrigo Company plc Vaginal Anti Infectives Product
Table 108. Perrigo Company plc Recent Developments/Updates
Table 109. Production Base and Market Concentration Rate of Raw Material
Table 110. Key Suppliers of Raw Materials
Table 111. Vaginal Anti Infectives Distributors List
Table 112. Vaginal Anti Infectives Customers List
Table 113. Vaginal Anti Infectives Market Trends
Table 114. Vaginal Anti Infectives Market Drivers
Table 115. Vaginal Anti Infectives Market Challenges
Table 116. Vaginal Anti Infectives Market Restraints
Table 117. Global Vaginal Anti Infectives Sales Forecast by Type (2023-2028) & (K Units)
Table 118. Global Vaginal Anti Infectives Sales Market Share Forecast by Type (2023-2028)
Table 119. Global Vaginal Anti Infectives Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global Vaginal Anti Infectives Revenue Market Share Forecast by Type (2023-2028)
Table 121. Global Vaginal Anti Infectives Sales Forecast by Application (2023-2028) & (K Units)
Table 122. Global Vaginal Anti Infectives Sales Market Share Forecast by Application (2023-2028)
Table 123. Global Vaginal Anti Infectives Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 124. Global Vaginal Anti Infectives Revenue Market Share Forecast by Application (2023-2028)
Table 125. Global Vaginal Anti Infectives Sales Forecast by Region (2023-2028) & (K Units)
Table 126. Global Vaginal Anti Infectives Sales Market Share Forecast by Region (2023-2028)
Table 127. Global Vaginal Anti Infectives Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 128. Global Vaginal Anti Infectives Revenue Market Share Forecast by Region (2023-2028)
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vaginal Anti Infectives
Figure 2. Global Vaginal Anti Infectives Market Share by Type in 2021 & 2028
Figure 3. Oral Product Picture
Figure 4. Ointment Product Picture
Figure 5. Global Vaginal Anti Infectives Market Share by Application in 2021 & 2028
Figure 6. Bacterial Vaginitis
Figure 7. Trichomonal Vaginitis
Figure 8. Candida Vaginitis
Figure 9. Global Vaginal Anti Infectives Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Vaginal Anti Infectives Market Size (2017-2028) & (US$ Million)
Figure 11. Global Vaginal Anti Infectives Sales (2017-2028) & (K Units)
Figure 12. Vaginal Anti Infectives Sales Share by Manufacturers in 2021
Figure 13. Global Vaginal Anti Infectives Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Vaginal Anti Infectives Players: Market Share by Revenue in 2021
Figure 15. Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Vaginal Anti Infectives Sales Market Share by Region (2017-2022)
Figure 17. Global Vaginal Anti Infectives Sales Market Share by Region in 2021
Figure 18. Global Vaginal Anti Infectives Revenue Market Share by Region (2017-2022)
Figure 19. Global Vaginal Anti Infectives Revenue Market Share by Region in 2021
Figure 20. United States Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Colombia Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Vaginal Anti Infectives Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Vaginal Anti Infectives by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Vaginal Anti Infectives
Figure 45. Manufacturing Process Analysis of Vaginal Anti Infectives
Figure 46. Vaginal Anti Infectives Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
